NCT00046670View on ClinicalTrials.gov

Sleep Disordered Breathing, APOE, and Lipid Metabolism

CompletedOBSERVATIONAL
Timeline

Start Date

September 30, 2002

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Sleep Apnea SyndromesLung Diseases
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Stanford University

OTHER

NCT00046670 - Sleep Disordered Breathing, APOE, and Lipid Metabolism | Biotech Hunter | Biotech Hunter